PRAC Again Warns Against Dolutegravir Use During Pregnancy PRAC Again Warns Against Dolutegravir Use During Pregnancy

The European Medicines Agency has confirmed its earlier precaution regarding the use of dolutegravir in women who are or who could become pregnant; it expects to make final recommendations next year.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news